Skip to main content

Beyond opioids: revisiting pain management in post cardiac surgery infants

The Original Article was published on 30 April 2024

Dear Editor,

The article titled “Intermittent intravenous paracetamol versus continuous morphine in infants undergoing cardiothoracic surgery: a multi-center randomized controlled trial” by G Zeilmaker-Roest et al. was read with great interest [1]. We appreciate the authors’ research and want to express our views about the article.

Perioperative pain control is an essential component in post-operative intensive care. Inadequately treated pain may have both short-term and long-term deleterious effects. An evidence-based guideline for pain treatment after cardiac surgery in children is lacking. Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) represent the most used non-opioid analgesics in children. In critically ill and post-operative children with moderate to severe pain, the SCCM PANDEM 2022 guideline recommends opioids as the primary analgesic [2]. Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) are also suggested as an adjunct to reduce opioid usage and enhance early postoperative recovery [2].

Opioids have been associated with potentially serious adverse events, such as hypotension and respiratory depression, apart from the risk of tolerance and withdrawal. This study aims to look for whether paracetamol can be used as an alternative. There was a significant difference in the cumulative dose of morphine in both groups with nearly 5 times less in the paracetamol group. However, the study could not find any differences in hemodynamic instability, apnoeic episodes, delirium, or pain control. A mere decrease in the cumulative dose of morphine may not be a clinically meaningful outcome if there are no differences in major clinical outcomes. Hence authors could have used a better clinically significant primary outcome.

The study used NRS -11 (Numeric rating scale) to assess pain control and the need for a bolus dose of morphine in case of inadequate pain control. Though the Comfort B score was also assessed, it was not used to identify the need for intermittent morphine boluses. NRS -11 is not a validated score below 6 years of age especially in a preverbal stage as they will not be able to express [3]. The study states that trained pediatric ICU nurses and parents assessed the score; it is not clear what objective parameters were taken into consideration for scoring and the participation of parents without much training in such a short duration of stay to decide an intervention is also questionable.

According to this study, 62% and 69% of the paracetamol and morphine groups, respectively, required rescue morphine doses. Patients in the morphine group needed higher rescue doses of morphine raising concern for the use of opioids as the primary analgesic in sick children [1]. Despite having a lesser risk for sedation, morphine is still known to cause sedation at higher blood levels especially when used in conjunction with other sedatives [4]. The cumulative dose of morphine in the morphine group was much higher than that of the paracetamol group. It was a bit surprising that there was no difference in sedation requirement in both groups. The study also assessed delirium and gastrointestinal side effects in the first 48 h, as the author mentions the effects might be masked due to shorter follow-up. Considering these are very common adverse effects even with a short course of opioids this study could have followed up these children for a longer time to look for delirium and withdrawal syndromes [5].

This study also found higher renal injury in the morphine group, though it was statistically not significant. Opioids are known to cause podocytopathy in chronic usage and result in AKI if acute overdosage. The mechanism of AKI in such patients is due to dehydration, hypotension, rhabdomyolysis, and urinary retention6. There were no such differences in such adverse events in both groups. The study mentions such difference is probably due to the renal protective effect of paracetamol which is not proven in children and needs more studies for same.

We appreciate the authors for their study of using paracetamol as an alternative to opioids in post-cardiac surgery infants. The study also emphasized the role of cardiopulmonary bypass, hypothermia, and post-cardiac surgery state on the pharmacokinetics and pharmacodynamics of opioids. Currently, opioids being used as the first choice as an analgesic in critically sick infants, NSAIDS, Paracetamol or any other analgesic with a different mechanism should be used as an adjunct or even alternative to opioids to reduce the side effects associated. We need more research to find a better choice of analgesic in post cardiac surgery patients which are not affected by CPB with better safety profile.

Availability of data and materials

Not applicable.

Abbreviations

AKI:

Acute kidney injury

CPB:

Cardiopulmonary bypass

NSAIDs:

Non-steroidal anti-inflammatory drugs

NRS:

Numeric rating scale

SCCM:

Society of Critical Care Medicine

References

  1. Zeilmaker-Roest G, de Vries-Rink C, van Rosmalen J, van Dijk M, de Wildt SN, Knibbe CA, et al. Intermittent intravenous paracetamol versus continuous morphine in infants undergoing cardiothoracic surgery: a multi-center randomized controlled trial. Crit Care. 2024;28(1):143.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Smith HA, Besunder JB, Betters KA, Johnson PN, Srinivasan V, Stormorken A, et al. 2022 Society of Critical Care Medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility. Pediatr Crit Care Med. 2022;23(2):e74-110.

    Article  PubMed  Google Scholar 

  3. Giordano V, Edobor J, Deindl P, Wildner B, Goeral K, Steinbauer P, et al. Pain and sedation scales for neonatal and pediatric patients in a preverbal stage of development: a systematic review. JAMA Pediatr. 2019;173(12):1186–97.

    Article  PubMed  Google Scholar 

  4. Morphine sulfate injection label—accessdata.fda.gov Reference ID: 3043802

  5. Ávila-Alzate JA, Gómez-Salgado J, Romero-Martín M, Martínez-Isasi S, Navarro-Abal Y, Fernández-García D. Assessment and treatment of the withdrawal syndrome in paediatric intensive care units: systematic review. Medicine. 2020;99(5):e18502.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mallappallil M, Bajracharya S, Salifu M, Yap E. Opioids and acute kidney injury. In Seminars in nephrology 2021 Jan 1 (Vol. 41, No. 1, pp. 11–18). WB Saunders.

Download references

Acknowledgements

Not applicable.

Funding

The study did not receive any funding.

Author information

Authors and Affiliations

Authors

Contributions

Siddannagoud Salotagi and Atul Jindal wrote the manuscript; Atul Jindal reviewed and revised the manuscript. Siddannagoud Salotagi and Atul Jindal contributed equally to this work. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Atul Jindal.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

None of the authors has any conflict of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salotagi, S., Jindal, A. Beyond opioids: revisiting pain management in post cardiac surgery infants. Crit Care 28, 193 (2024). https://doi.org/10.1186/s13054-024-04983-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-024-04983-3

Keywords